SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Rexahn Pharmaceuticals, Inc. with Ocuphire Pharma, Inc. is Fair to REXN Shareholders

New York, New York--(Newsfile Corp. - June 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) ("Rexahn" or the "Company") stock prior to June 17, 2020.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Rexahn with Ocuphire Pharma, Inc. ("Ocuphire"). Under the terms of the merger, Ocuphire will merge with a wholly-owned subsidiary of Rexahn, with Ocuphire surviving the merger as a wholly-owned subsidiary of Rexahn. Following the merger, the combined company will change its name to Ocuphire Pharma, Inc. and is expected to trade on the Nasdaq Capital Market under the ticker symbol "OCUP." Rexahn's then-current stockholders would own approximately 14.3% of the combined company's common stock, and the former Ocuphire securityholders would own approximately 85.7% of the combined company's common stock, in each case calculated on a fully-diluted basis. To learn more about the action and your rights, go to:

https://www.zlk.com/mna2/rexahn-pharmaceuticals-inc-information-request-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The Rexahn merger investigation concerns whether the Board of Rexahn breached their fiduciary duties to stockholders by agreeing to enter into this transaction and whether the merger undervalues Rexahn relative to Ocuphire, thereby harming Rexahn shareholders.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58316